Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain (Molecular Psychiatry, (2021), 26, 10, (5766-5788), 10.1038/s41380-020-0806-5)

LonDownS Consortium

Research output: Contribution to journalComment/debatepeer-review

3 Citations (Scopus)

Abstract

Following the online publication, the authors discovered they made an error in Table 1, in the column entitled “APOE”, the last entry at the bottom of this column has been wrongly entered as “3,3”, it should be corrected to “3,4”. This error does not change anything in Results, Discussion or Conclusions of the work (no experiments were based on the ApoE genotype). The original article has been corrected.

Original languageEnglish
Pages (from-to)5789
Number of pages1
JournalMolecular Psychiatry
Volume26
Issue number10
DOIs
Publication statusPublished - Oct 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature Limited 2021.

ASJC Scopus Subject Areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain (Molecular Psychiatry, (2021), 26, 10, (5766-5788), 10.1038/s41380-020-0806-5)'. Together they form a unique fingerprint.

Cite this